What is the impact of clopidogrel in patients with acute coronary syndromes requiring coronary artery bypass surgery?
A multicenter analysis published in the Journal of the American College of Cardiology (2008) found that clopidogrel has a significant impact on the outcomes of patients with acute coronary syndromes requiring coronary artery bypass surgery. The analysis showed that the use of clopidogrel was associated with increased graft patency, reduced need for repeat revascularization, and improved clinical outcomes at 1-year follow-up.